Sixsigma Medicare And Research Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 5.05 Cr
as on 17-07-2024
- Paid Up Capital ₹ 1.97 Cr
as on 17-07-2024
- Company Age 12 years 6 months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 17.85 Cr
as on 17-07-2024
- Satisfied Charges ₹ 30.08 Cr
as on 17-07-2024
- Revenue -29.87%
FY 2022
- Profit -99.66%
FY 2022
- Ebitda -41.43%
FY 2022
- Net Worth 0.35%
FY 2022
- Total Assets -8.39%
FY 2022
About Sixsigma Medicare And Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.05 Cr and a paid-up capital of Rs 1.97 Cr.
The Corporate currently has active open charges totaling ₹17.85 Cr. It has already closed loans amounting to ₹30.08 Cr, as per the Ministry of Corporate Affairs (MCA) records.
Gauri Mahajan, Rashmi Kochar, Paratikshit Mahajan, and One other member serve as directors at the Company.
- CIN/LLPIN
U74900MH2012PLC228349
- Company No.
228349
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sixsigma Medicare And Research?
Board Members(4)
Financial Performance and Corporate Structure Insights of Sixsigma Medicare And Research.
Sixsigma Medicare And Research Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 29.87% decrease. The company also saw a substantial fall in profitability, with a 99.66% decrease in profit. The company's net worth moved up by a moderate rise of 0.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sixsigma Medicare And Research?
In 2022, Sixsigma Medicare And Research had a promoter holding of 99.80% and a public holding of 0.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pulse Superspeciality Clinic Llp
Active
6 years 11 months Paratikshit Mahajan and Nitin Kochar are mutual person
Sapta Ganga Healthcare Private Limited
Active 3 years 5 months Paratikshit Mahajan and Nitin Kochar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 May 2023 | ₹16.90 Cr | Open |
Others Creation Date: 28 Sep 2020 | ₹2.50 M | Open |
Others Creation Date: 25 Aug 2018 | ₹0.54 M | Open |
How Many Employees Work at Sixsigma Medicare And Research?
Sixsigma Medicare And Research has a workforce of 104 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Nov 23, 2019, Sixsigma Medicare And Research has raised a total of ₹ 3.85 Cr, with the most recent deal valued at ₹ 1.2 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
